US Stock Market Closed

Dashboard

BIOLASE, Inc. (BIOL)

Current

- (-)

After Hours

Rating & Fair Value

Fair Value Premium lock
Institutional Holdings

H

Financial Strength

H

Sustainable Growth

S

Industry Comparison

H

Management & Equity

S

Analyst Opinion

B

Leverage & Liquidity

B

Fundamental Variables

S

Rating Performance

FV Performance

About

BIOLASE, Inc. is a medical device company, which engages in developing, manufacturing, marketing and sale of laser systems in dentistry and medicine. It operates through Waterlase (all-tissue) systems, and Diode (soft-tissue) systems products. The Waterlase systems uses a patented combination of water and laser energy to perform procedures using drills, scalpels, and other traditional dental instruments for cutting soft and hard tissue. The Diode systems performs soft tissue, pain therapy, and cosmetic procedures, including teeth whitening. The company was founded in 1987 and is headquartered in Irvine, CA.

CEO

Todd A. Norbe

Employees

157

Industry

-

Sector

-

Headquarters

Irvine

Exchange

NASDAQ

Summary Stats

Market Cap

6M

Revenue

46.8M

Net Income

-23.7M

EPS

-$3.64

Price-to-Earnings

-0.23

Price-to-Book

0.43

Debt-to-Equity

2.09

News

Analyst Ratings

Price targets projected by 4 analysts

High

$2.00

Average

$1.41

Low

$1.00

Ratings calculated by 4 analysts

Buy

4

Hold

0

Sell

0

Last Dividend

Amount

-

Dividend Date

-

Frequency

-

Dividend Yield

Earnings

Most Recent Earnings

Last Earnings for Q3 2022

Last Earnings

Missed by -$0.26

Actual

-$1.10 -31.0%

Consensus

-0.84

Report Date

Year Ago

-0.02

Year Ago Change %

Down 5400%

Actual vs Estimates

XX

xxx

Upcoming Estimates Unavailable

Expected EPS
-

-

Actual EPS
-

--

Competitors

star Favorites